committee here
During the Two Sessions this year, Li Weimin, a member of the National Committee of the Chinese People's Political Consultative Conference and president of West China Hospital of Sichuan University, suggested that low-dose spiral CT lung cancer screening should be included in the national screening plan, and the inspection fee should be included in medical insurance reimbursement.
"Low-dose spiral CT can detect curable early lung cancer. It is recommended as the main method of lung cancer screening in all countries in the world. my country has included low-dose spiral CT screening in the guidelines for lung cancer screening. However, high-risk groups of lung cancer receive screening The proportion of the disease is still low, and it has not yet been fully popularized.” Li Weimin introduced that the main reason is that 96% of the current cost of lung cancer prevention and treatment is spent on treatment, and the composition of prevention costs is extremely low.
If early screening of lung cancer is included in medical insurance reimbursement, it will greatly increase the participation of high-risk groups in screening, promote the advancement of lung cancer prevention and treatment, and solve the core problem of "the last mile" of early diagnosis and treatment of lung cancer.
According to the latest data from the National Cancer Center, the number of malignant tumors in my country is increasing year by year. It is estimated that the number of patients will be 5.2 million in 2025 and 5.8 million in 2030.
Among them, lung cancer has an annual incidence of 828,000 people and an annual death of 657,000 people, both of which rank first in malignant tumors. The overall five-year survival rate of lung cancer patients is significantly lower than that of the United States and other developed countries. The main reason is that 68% of lung cancer patients in my country were diagnosed at the time It is already at an advanced stage, and the proportion is much higher than that in other countries, which shows that the early screening and early diagnosis rate of lung cancer in China still needs to be strengthened.
"From the perspective of health economics, the cost of early screening of lung cancer is far lower than the cost of medical insurance and personal payment when the disease is late. In the long run, advancing the prevention and treatment of lung cancer can not only improve the survival rate of patients , It can also effectively reduce medical expenses.” Li Weimin said.
West China Metropolis Daily - Cover News Reporter Ning Zhi